These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Growing points in leprosy research. 4. Recent advances in the chemotherapy of leprosy. Ellard GA Lepr Rev; 1974 Mar; 45(1):31-40. PubMed ID: 4136027 [No Abstract] [Full Text] [Related]
5. The drug treatment of leprosy. Browne SG Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470 [No Abstract] [Full Text] [Related]
6. Chemotherapy of leprosy. Leiker DL Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084 [No Abstract] [Full Text] [Related]
7. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
8. [On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations]. Floch HA Bull Soc Pathol Exot Filiales; 1966; 59(2):188-92. PubMed ID: 6012833 [No Abstract] [Full Text] [Related]
9. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
10. Chemotherapy in Leprosy. Leiker DL Int J Dermatol; 1975 May; 14(4):254-62. PubMed ID: 1093982 [No Abstract] [Full Text] [Related]
11. The control of neuritis in leprosy with clofazimine. Pfaltzgraff RE Int J Lepr Other Mycobact Dis; 1972; 40(4):392-8. PubMed ID: 4586401 [No Abstract] [Full Text] [Related]
12. Experimental chemotherapy in leprosy, then and now. Shepard CC Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732 [No Abstract] [Full Text] [Related]
13. [Current treatment of leprosy in the Malta pavilion of the Hôpital Saint-Louis]. Pennec J Ann Med Interne (Paris); 1974; 125(6-7):561-4. PubMed ID: 4440971 [No Abstract] [Full Text] [Related]
14. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli. Waters MF; Rees RJ; McDougall AC; Weddell AG Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977 [No Abstract] [Full Text] [Related]
15. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
16. Follow-up of smear-positive cases treated with dapsone monotherapy. Naik SS; Shere SS Indian J Lepr; 1997; 69(2):196-7. PubMed ID: 9290975 [No Abstract] [Full Text] [Related]
17. Lepromatous leprosy in the nose after one year of dapsone treatment: clinical and bacteriological findings. Barton RP; Hogerzeil LM Lepr Rev; 1975 Dec; 46(4):257-65. PubMed ID: 1107725 [No Abstract] [Full Text] [Related]
18. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. Chen XS; Li WZ; Jiang C; Ye GY Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910 [TBL] [Abstract][Full Text] [Related]
19. [Suspicion of paucibacillary leprosy resistant to dapsone: importance of follow-up]. Husser JA; Pattyn SR Acta Leprol; 1987; 5(2):147-50. PubMed ID: 3303807 [TBL] [Abstract][Full Text] [Related]
20. Appearance of resistance during prolonged treatment of leprosy with Thiambutosine. Garrod JM; Ellard GA Lepr Rev; 1968 Jul; 39(3):113-7. PubMed ID: 5663677 [No Abstract] [Full Text] [Related] [Next] [New Search]